India procures 100 mln doses of Russian vaccine from Covid-19

Source : 112 Ukraine

Dr Reddy’s pharmaceutical company will run Phase 3 of the clinical trials
13:48, 16 September 2020

Open source

Russia is ready to sell 100,000,000 doses of Sputnik-V vaccine to India. The country's Direct Investment Fund reported that on September 16. 

"Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement. Deliveries to India could begin in late 2020, it said, adding this was subject to the completion of trials and the vaccine’s registration by regulatory authorities in India", reads the story by Reuters.

Related: Russia's Sputnik vaccine gamble is all about Vladimir Putin

Unline scientists in Europe and the U.S., the Indian side shows trust for the new vaccine claiming that it "could provide a credible option in our fight against COVID-19 in India", as G.V. Prasad, co-chairman of Dr Reddy’s put it.

Currently, the number of Covid-19 cases registered in India exceeded five million.

Related: Brazil intends to buy 50 million doses from Russian Sputnik V vaccine against Covid-19

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more